Orange Book product · Generic (ANDA)
PERPHENAZINE
PERPHENAZINE
At a glance
Apr 14, 2017
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 14, 2017
9 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
PERPHENAZINE
Strength
2MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 206691
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PERPHENAZINE
- —TRILAFONBrand (NDA)
NDA 011557 · SCHERING
- —TRILAFONBrand (NDA)
NDA 011213 · SCHERING
- —TRILAFONBrand (NDA)
NDA 011294 · SCHERING
- —TRILAFONBrand (NDA)
NDA 011361 · SCHERING
- —TRILAFONBrand (NDA)
NDA 010775 · SCHERING
- 2025PERPHENAZINEGeneric (ANDA)
ANDA 213694 · JUBILANT GENERICS
- 2024PERPHENAZINEGeneric (ANDA)
ANDA 212545 · MACLEODS PHARMS LTD
- 2022PERPHENAZINEGeneric (ANDA)
ANDA 210163 · APPCO
- 2020PERPHENAZINEGeneric (ANDA)
ANDA 205232 · ZYDUS PHARMS
- 2019PERPHENAZINEGeneric (ANDA)
ANDA 205056 · RISING
- 2016PERPHENAZINEGeneric (ANDA)
ANDA 207582 · WATSON LABS INC
- 2015PERPHENAZINEGeneric (ANDA)
ANDA 205973 · WILSHIRE PHARMS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
